#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15522	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2001	766.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1390	1390	C	921	C	863	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27822	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3672	755.9	0	.	n	.	0	T695C	SNP	695	695	T	1132	1132	C	848	C	794	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27822	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3672	755.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2075	2075	G	910	G,A	844,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27822	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3672	755.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2408	2408	C	930	C	851	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27822	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3672	755.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2482	2482	A	885	A	823	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27822	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3672	755.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3034	3034	C	832	C	767	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2372	folP	855	855	100.0	folP.l15.c4.ctg.1	1518	155.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1021	1023	AGC	232;234;234	A;G;C	216;221;217	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5836	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3460	168.1	1	SNP	p	S91F	1	.	.	271	273	TTC	656	658	TTC	205;203;205	T;T;C	190;191;192	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5836	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3460	168.1	1	SNP	p	D95G	1	.	.	283	285	GGC	668	670	GGC	207;207;207	G;G;C	196;195;196	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5836	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3460	168.1	1	SNP	p	G95N	0	.	.	283	285	GGC	668	670	GGC	207;207;207	G;G;C	196;195;196	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1818	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1384	130.6	1	SNP	p	G45D	0	.	.	133	135	GGC	541	543	GGC	217;218;218	G;G,A;C	199;197,1;197	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	940	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	935	99.9	0	.	n	.	0	A197.	DEL	197	197	A	535	535	A	208	A	199	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5248	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3093	168.9	1	SNP	p	D86N	0	.	.	256	258	GAC	606	608	GAC	209;213;213	G;A;C	194;195;196	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5248	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3093	168.9	1	SNP	p	R87W	0	.	.	259	261	CGT	609	611	CGT	213;215;214	C;G;T	195;199;197	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5248	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3093	168.9	1	SNP	p	S87R	1	.	.	259	261	CGT	609	611	CGT	213;215;214	C;G;T	195;199;197	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5248	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3093	168.9	1	SNP	p	R87I	0	.	.	259	261	CGT	609	611	CGT	213;215;214	C;G;T	195;199;197	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5248	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3093	168.9	1	SNP	p	S88P	0	.	.	262	264	TCC	612	614	TCC	213;211;208	T;C;C	193;194;189	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5028	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2627	190.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1544	1546	GGC	249;250;252	G;G;C	226;229;225	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	180.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1307	1309	GCC	272;272;270	G;C;C	251;254;253	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	180.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1310	1312	ATG	271;271;274	A;T;G	254;254;257	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	180.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1322	1324	ACC	271;274;280	A;C;C	249;256;263	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	180.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1322	1324	ACC	271;274;280	A;C;C	249;256;263	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	180.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1823	1825	ACC	215;214;214	A;C;C	191;194;192	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	180.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1877	1879	GCG	219;217;217	G;C;G	206;205;205	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	180.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1877	1879	GCG	219;217;217	G;C;G	206;205;205	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	180.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2000	2002	GGT	189;187;185	G,A;G;T	173,1;173;169	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	180.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2009	2011	AGC	182;180;181	A;G;C	164;164;161	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4450	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	180.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2027	2029	CCG	166;169;166	C,G;C,G;G	127,7;133,1;126	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6098	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3213	188.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1565	1567	CCG	210;212;211	C;C;G	185;195;186	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2688	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1757	151.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	510	510	C	172	C	155	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3054	porB1b	1038	1038	97.65	porB1b.l15.c4.ctg.1	1562	193.8	0	.	p	.	0	K222trunc	TRUNC	664	664	A	922	922	A	269	A	248	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3054	porB1b	1038	1038	97.65	porB1b.l15.c4.ctg.1	1562	193.8	1	SNP	p	G120K	1	.	.	358	360	AAG	616	618	AAG	278;276;276	A;A;G	260;262;257	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3054	porB1b	1038	1038	97.65	porB1b.l15.c4.ctg.1	1562	193.8	1	SNP	p	A121N	1	.	.	361	363	AAC	619	621	AAC	276;273;274	A;A;C	258;256;255	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3054	porB1b	1038	1038	97.65	porB1b.l15.c4.ctg.1	1562	193.8	1	SNP	p	N121D	0	.	.	361	363	AAC	619	621	AAC	276;273;274	A;A;C	258;256;255	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10764	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4810	223.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1188	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1160	101.9	1	SNP	p	V57M	1	.	.	169	171	ATG	540	542	ATG	245;245;241	A;T;G	232;231;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
